Joan Temmerman, MD, MPH, MS, FAAFP, CNS: Nothing to disclose
Eric C. Westman, MD, MHS, MFOMA: Vivus: National Advisory Board, Speakers Bureau; Eisai: Speakers Bureau; KE Diet: Scientific Advisory Board Member
Stan Anderson, MD: GlaxoSmithKline: Consultant
Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Board, Consultant, Speakers Bureau
Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Consultant, Speakers Bureau, Advisory Activities, Development of Educational Material; Takeda Pharmaceuticals: Speakers Bureau ; Eisai: Advisory Board; Covidian: Consultant
Michael Bateman, DO: Mead Johnson: Speaker
Erin Chamberlin, MD, FAAFP, FOMA: Takeda Pharmaceuticals: Speakers Bureau
Sarah Hallberg, DO: KetoThrive: Research Activities
Myra L. Muramoto, MD, MPH: Sanofi-Aventis: Holdings
Stephen J. Petteruti, DO: Metagenics: Speakers Bureau
Thomas C. Varughese, MD: Takeda: Speaker’s Bureau; Holdings
Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy: Advisory Board; Various Book Royalties; Vivus: National Advisory Board, Speakers Bureau; Eisai: Speakers Bureau; KE Diet
Nothing to Disclose: Michael Arata, MD; Crystal Broussard, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Marcie Gonzales; Brent Gear, DO; Charles Halliman; Valentina Jordan; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; Kevin Rosenberg, MD; William Jeffrey McDaniel, MD; Stephen J. Petteruti, DO; Scott Rigden, MD, FAAFP, MFOMA; Stacy Schmidt, PhD; Harold Seim, MD, MPH, FOMA; Laurie Traetow, CAE
The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The OMA designates this enduring material internet activity for a maximum of 8 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
July 01, 2016
June 01, 2019 12:00 AM
Identify the latest dietary and health fads for the treatment of obesity and explain the scientific or lack of scientific evidence for the safety and efficacy of these products or procedures.
Implement a carbohydrate-restricted diet for the treatment of obesity and related disease based on evidence from medical literature.
Understand the current medical evidence both for and against the use of non-nutritive sweeteners in the treatment of obesity and related diseases.
Inform patients of essential nutrition information, including function and sources of macronutrients and micronutrients.
Learn about the chemistry, physiology, and epidemiology of dietary fat, including the much-maligned saturated fat.
Understand and prescribe the low-glycemic load and high-phytonutrient diet.
Review the effect the processed food industry has had on food consumption.
Explore the differences between real and processed foods.
Describe the effect of processed food consumption on health outcomes, environment, and spending.
Identify the major functions of the immune system.
Identify the importance of the microbiome in immunity and the impact of diet on the microbiome.
Identify how diet and obesity alter these immune functions.
Examine the role of protein in weight management.
Investigate various nutritional approaches/protocols for weight loss.
Illustrate the evidence supporting clinical meal replacements.
Recognize the advantages and disadvantages of various diet plans in order to develop the most effective dietary weight-loss program to individual patient needs.